My Companies
Notification
Account
Log Out
Login
Deepak Anand will resign as CEO of wholly owned subsidiary Shalby MedTech effective September 4, 2026, citing plans to move abroad for personal reasons. The company stated there is no other material reason and that he will ensure an orderly handover.
Shalby Shareholders Reject Shanay Vikram Shah's Director Appointment
Shalby Secures ₹129.7 Crore Working Capital Facility From Kotak Mahindra Bank